HEALTH

Patient Views - November 2013 Methodology
AccentHealth collected data through an online survey conducted from Oct. 14 to 21. Participants responded via AccentHealth's national, online panel of network viewers, and the survey yielded 520 respondents who were at least 18 years of age, and either themselves or a household member have prediabetes, Type 1 diabetes or Type 2 diabetes.

All data is self-reported and not validated.

Below is the demographic breakdown of the respondents and their behavior:

Gender
WSJ: J&J temporarily suspends shipments to Amazon.com over third-party resellers
NEW YORK — Johnson & Johnson had temporarily stopped distribution of its products to Amazon.com over concerns that Amazon hasn't done enough to prevent third-party resellers from selling damaged or expired J&J products on Amazon's site, according to a report published Sunday by The Wall Street Journal.

Births among older consumers on the rise

The buying demographic for pregnancy test kits and ovulation test kits may be skewing older.

(For the full category review, including sales data, click here.)
Topricin addition soothes foot, ankle pain

RHINEBECK, N.Y. — Topical BioMedics recently gained distribution for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics. The cream has been specially formulated to address issues associated with foot and ankle pain and injuries.
ADA pushes nutrition therapy

Supermarket pharmacy operators last month received validation for the growing number of diabetes educators and dietary nutritionists walking their aisles. In the Oct. 9 issue of Diabetes Care, the American Diabetes Association recommended all people with diabetes make nutrition therapy a part of their treatment plan.
Blog: Sanofi sues FDA to delay publication of OTC Nasacort labeling

WASHINGTON — Sanofi-Aventis has sued the Food and Drug Administration to keep its labeling for OTC Nasacort confidential in an effort to delay store brand competition until after the launch, according to an entry in the FDA Law Blog, the official blog of Hyman, Phelps & McNamara, published Thursday.
OraQuick delivers speedy diagnosis

BETHLEHEM, Pa. — With more than $7.2 million in sales for the 52 weeks ended Sept. 8, the landmark launch of Orasure Technologies’ OraQuick In-Home HIV test last year was a key driver behind the 11.7% growth in the home-test kit across U.S. multi-outlets, according to IRI. The OraQuick In-Home HIV Test detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes.
Fitness technology units expected to race off shelves

Earlier this year, Walgreens introduced a significant boost to its Steps with Balance Rewards program, enabling users to link wireless activity trackers such as FitBit, Withings and BodyMedia to the aspirational wellness program. Loyalty cardholders who sync with one of these devices get two times the points associated with healthier behaviors — 20 points per mile and 20 points per day for tracking their weight. And each device linked earns 250 points.
Glucerna Advance shakes things up

ABBOTT PARK, Ill. — Abbott recently introduced a nutrition shake called Glucerna Advance that is formulated for people with diabetes who are seeking additional nutrition and health benefits. The new product helps to minimize blood sugar spikes while supporting heart hearth and the immune system.
Creating a diabetes ecosystem

Creating a home destination center for diabetic patients stocked with products appropriate to their condition —not only including sugar tablets, gels and liquids, but also nutritional supplements, homeopathic products, skin creams and lotions, oral care solutions, pain relief products and hypoglycemic products — has gained in importance thanks to the price pressures associated with competitive bidding in the diabetes space.